Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 47 min ago

Poor Customer Data Management Costs Pharma Companies Money: Report

Fri, 10/04/2024 - 02:00
Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024

AACR 2024: What Cancer Researchers Are Talking About

Fri, 10/04/2024 - 02:00
AACR 2024: What Cancer Researchers Are Talking About 4/10/2024

Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data

Wed, 09/04/2024 - 02:00
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data 4/9/2024

Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs

Wed, 09/04/2024 - 02:00
Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs 4/9/2024

FDA Backs BrainStorm’s Design for Phase IIIb Trial in Early-Stage ALS

Wed, 09/04/2024 - 02:00
FDA Backs BrainStorm’s Design for Phase IIIb Trial in Early-Stage ALS 4/9/2024

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk

Wed, 09/04/2024 - 02:00
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk 4/9/2024

AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report

Wed, 09/04/2024 - 02:00
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report 4/9/2024

Merck, Essential Pharma, CoreRx and More Continue 2024 M&A Upswing

Wed, 09/04/2024 - 02:00
Merck, Essential Pharma, CoreRx and More Continue 2024 M&A Upswing 4/9/2024

Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs

Sun, 08/04/2024 - 02:00
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs 4/8/2024

BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win

Sun, 08/04/2024 - 02:00
BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win 4/8/2024

ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint

Sun, 08/04/2024 - 02:00
ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint 4/8/2024

5 Successful Phase III Oncology Trials in Q1

Sun, 08/04/2024 - 02:00
5 Successful Phase III Oncology Trials in Q1 4/8/2024

The Next Wave of ADCs Could Treat Evasive Solid Tumors

Sun, 08/04/2024 - 02:00
The Next Wave of ADCs Could Treat Evasive Solid Tumors 4/8/2024

AstraZeneca, Daiichi Sankyo Win First Tumor-Agnostic HER2 FDA Approval for Enhertu

Sun, 08/04/2024 - 02:00
AstraZeneca, Daiichi Sankyo Win First Tumor-Agnostic HER2 FDA Approval for Enhertu 4/8/2024

FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease

Sun, 08/04/2024 - 02:00
FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease 4/8/2024

Opinion: The Next Generation of ADCs Will Improve Cancer Treatment

Sun, 08/04/2024 - 02:00
Opinion: The Next Generation of ADCs Will Improve Cancer Treatment 4/8/2024

FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment

Tue, 06/04/2024 - 02:00
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024

AstraZeneca’s Imfinzi Clinches Late-Stage Victory in Aggressive Lung Cancer

Sat, 05/04/2024 - 02:00
AstraZeneca’s Imfinzi Clinches Late-Stage Victory in Aggressive Lung Cancer 4/5/2024

Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials

Sat, 05/04/2024 - 02:00
Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials 4/5/2024

Networking, ADCs and Early Science on the Agenda at AACR 2024

Sat, 05/04/2024 - 02:00
Networking, ADCs and Early Science on the Agenda at AACR 2024 4/5/2024